0
Sign In  | Subscribe
15 October 2002, Vol 137, No. 8>
Summaries for Patients | 15 October 2002

Ximelagatran versus Warfarin To Prevent Blood Clots after Knee Replacement Surgery FREE

[+] Article and Author Information

The summary below is from the full report titled “Ximelagatran versus Warfarin for the Prevention of Venous Thromboembolism after Total Knee Arthroplasty. A Randomized, Double-Blind Trial.” It is in the 15 October 2002 issue of Annals of Internal Medicine (volume 137, pages 648-655). The authors are CW Francis, BL Davidson, SD Berkowitz, PA Lotke, JS Ginsberg, JR Lieberman, AK Webster, JP Whipple, GR Peters, and CW Colwell Jr.


Ann Intern Med. 2002;137(8):I-38. doi:10.7326/0003-4819-137-8-200210150-00003
Text Size: A A A

What is the problem and what is known about it so far?

Deep venous thrombosis (DVT), a condition in which blood clots form in leg veins and cause pain and swelling, is a common complication of knee replacement surgery. Pieces of these clots can break off and travel to the lungs, causing a serious and potentially deadly condition called pulmonary embolism. To prevent DVT, doctors prescribe blood thinners around the time of knee replacement surgery. Warfarin is a common blood thinner used for this purpose. Unfortunately, up to almost half of patients still develop DVT after knee replacement surgery even if they take warfarin. In addition, warfarin requires frequent blood tests and dose changes to make sure that patients are getting an appropriate amount of the drug. Ximelagatran is a newer blood thinner that has shown some promise in preventing DVT after hip and knee replacement surgery. An advantage of ximelagatran is that it does not require blood tests or dose changes.

Why did the researchers do this particular study?

To compare warfarin and ximelagatran in the prevention of DVT after knee replacement surgery.

Who was studied?

680 patients who had total knee replacement surgery at one of 74 North American hospitals.

How was the study done?

The researchers randomly assigned patients to get 1) ximelagatran twice a day beginning on the morning of the day of surgery or 2) warfarin once daily starting the evening of the day of surgery. They followed patients with tests to look for DVT, pulmonary embolism, and bleeding complications.

What did the researchers find?

Deep venous thrombosis occurred at similar rates in both groups. Bleeding complications were also similar in both groups.

What were the limitations of the study?

This study had limited ability to compare the side effects of ximelagatran and warfarin.

What are the implications of the study?

Ximelagatran seems to be a reasonable option for preventing DVT after knee replacement surgery.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general jounals
BMJ 2010;341:c5893-c1494.

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Advertisement

Related Content

Customize your page view by dragging & repositioning the boxes below.

Topic Collections

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)